0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Investigation | 
Charles C. van Rossem, MD; Marc H. F. Schreinemacher, MD, PhD; Anna A. W. van Geloven, MD, PhD; et al.
JAMA Surg. 2016;151(4):323-329. doi:10.1001/jamasurg.2015.4236.
Includes: CME

Original Investigation |  ONLINE FIRST
Yi Li, MD, PhD; Luca Stocchi, MD; Deepa Cherla, MD; et al.
JAMA Surg. Published online February 24, 2016. doi:10.1001/jamasurg.2015.5558

From the JAMA Network | 
Elliott R. Haut, MD, PhD
JAMA Surg. 2016;151(2):191-192. doi:10.1001/jamasurg.2015.4218.

Research Letter | 
Brandyn D. Lau, MPH, CPH; Michael B. Streiff, MD; Peter J. Pronovost, MD, PhD; et al.
JAMA Surg. 2015;150(8):813-814. doi:10.1001/jamasurg.2015.0891.

Invited Commentary | 
Eric K. Nakakura, MD, PhD
JAMA Surg. 2014;149(5):466. doi:10.1001/jamasurg.2013.5282.

Original Investigation |  FREE
Raymond F. Lamore III, PharmD; Elizabeth M. Hechenbleikner, MD; Christina Ha, MD; et al.
JAMA Surg. 2014;149(5):459-466. doi:10.1001/jamasurg.2013.5278.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Internal Medicine
Invited Commentary  | 
Prescription of Brand-Name Medications When Generic Alternatives Are Available—Patently Unfair
Walid F. Gellad, MD, MPH; Chester B. Good, MD, MPH
JAMA Internal Medicine
Original Investigation  | 
Effect of Generic Competition on Atorvastatin Prescribing and Patients’ Out-of-Pocket Spending
Jing Luo, MD, MPH; John D. Seeger, PharmD, DrPH; Macarius Donneyong, PhD; et al.
JAMA Ophthalmology
Invited Commentary  | 
Physician-Industry Interactions and Anti–Vascular Endothelial Growth Factor Use Among US Ophthalmologists
Paul R. Lichter, MD
JAMA Ophthalmology
Original Investigation  | 
Physician-Industry Interactions and Anti–Vascular Endothelial Growth Factor Use Among US Ophthalmologists
Stanford C. Taylor, MD; Julia B. Huecker, MS; Mae O. Gordon, PhD; et al.